Nath Bio-Genes: FY26 Revenue ₹431.6 Mn, Dividend ₹2/Share

Nath Bio-Genes (India) Ltd's board meeting on May 4, 2026, approved the standalone and consolidated financial results for the quarter and year ended March 31, 2026. The company reported revenue from operations of ₹431.6 million for FY26. The board recommended a dividend of ₹2 per equity share (20%) subject to shareholder approval. Mr. Hitesh Rajnikant Purohit was re-appointed as an Independent Director for a second term of five years. M/s K.P. Sahasrabudhe & Co. was appointed as Internal Auditor for FY 2026-27. The remuneration of Managing Director, Mr. Satish Kagliwal, was increased to ₹14.4 million per annum, effective January 1, 2026, subject to shareholder approval.